| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Comm &Medical Affairs | SVP, Comm &Medical Affairs
1 company
Farnum Rhonda is a SVP, Comm &Medical Affairs at TBPH. Recent filings cover 0 purchases and 24 sales.
Our model assigns Farnum Rhonda a middling insider score of 51/100, based on 14 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -24.9%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 1,378 | $10.29 | $14,179.62 | -0.4% | -13.2% | -3.0% | |
| Aug 22, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 1,807 | $9.47 | $17,112.29 | -0.5% | +9.9% | -14.8% | |
| Jun 8, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 1,790 | $11.13 | $19,922.70 | -0.5% | -14.3% | -21.3% | |
| Mar 9, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 4,000 | $10.20 | $40,800.00 | -1.1% | +9.0% | -15.9% | |
| May 23, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 1,081 | $8.93 | $9,653.33 | -0.3% | -3.5% | +17.4% | |
| Feb 28, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Comm &Medical Affairs | Sell | 2,356 | $10.16 | $23,946.62 | -0.7% | -12.8% | +7.2% |